One mechanism proposed to play a role in T-cell depletion in human immunodeficiency virus (HIV) infection is apoptosis (activation-induced cell death). We assessed whether apoptosis is related to activation of T cells in vivo and i t s possible triggers. DNA was extracted from peripheral blood mononuclear cells IPBMC) taken from 16 vertically HIV-infected children and 9 HIV-negative children born to HIV-positive mothers (controls) and tested by agarose gel electrophoresis for the presence of DNA fragments specific for apoptosis. Signs of apoptosis were found on in vitro culture of PBMC from 12 of 16 HIV-infected children, but not in PBMC from the nine controls. Eleven of the 12 HIV-infected children with apoptosis showed an elevated (>15%) proportion of CD3'/HLA-DR+ cells. This was due to an increased proportion of CD8'/HLA-DR+ cells, as shown in 7 of 7 further tested patients. In none of the probands an increased (>5%) proportion of 11-2 receptor expressing CD3' cells was found. T cells undergoing apoptosis were preferentially of the CD8' phenotype. Expansion of circulating CDl+/interleukin-P re-
NFECTION WITH THE human immunodeficiency virus (HIV) eventually results in dysfunction and loss of T cells. The mechanisms leading to T-cell depletion are not clear. One of the proposed mechanisms is cell death by apoptosis (activation-induced cell death)."3
Apoptosis is a form of cell death distinct from necrosis. Whereas necrosis is the consequence of damage to the cell membrane by events such as toxic injury or hypoxemia, apoptosis relates to cellular suicide upon possibly inadequate activation of endonucleases resulting in digestion of the cell's own Because the DNA in nucleosomes wrapped around histones is not uniformly exposed to endonucleases, a ladder pattern pathognomonic for apoptosis appears in DNA gel electrophoresis, corresponding to the size of DNA packed per nucleosome (-200 bp) and multimers of them. The trigger for endonuclease activation is not known.
The course of HIV infection in children may differ from the course in adults. Because vertically HIV-infected chil-0 1995 by The American Society of Hematology. 00W-4971/95/8604-0026$3.00/0 1400 ceptor (IL-2R)-/HLA-DR+ T cells is known to occur during active infection with herpes viruses. To investigate the possible role of herpes viral coinfections for apoptosis in HIV infection, we focused on Epstein-Barr virus (EBV) as an example for a herpes virus usually acquired during childhood. In 10 of 12 patients with apoptosis. we found increased levels of EBV genome in PBMC and/or tissues, indicating active EBV replication. By contrast, no increased burden of EBV was found in the four HIV-infected patients without apoptosis or in the controls. Our data indicate that in children the occurrence of apoptosis in HIV infection is closely related to activation of CD8' T cells. Furthermore, primoinfection with or reactivation of herpes viruses, such as EBV, may substantially contribute to such T-cell activation and the ensuing apoptosis. Additional studies are warranted to evaluate the contribution of herpes virus-triggered apoptosis to the T-cell loss leading to the acquired immunodeficiency syndrome. dren acquire HIV at a time when the immune system is still developing, mechanisms leading to T-cell depletion may differ from those in adult HIV-infected individuals. The present study assesses whether apoptosis is related to activation of T cells in vivo and possible triggers of such activation. We found that apoptosis of peripheral blood mononuclear cells (PBMC) occurs in vertically HIV-infected children. The occurrence of apoptosis was associated with expansion of CD8+ interleukin-2-receptor (IL-2R)-/HLA-DR' T cells, which in turn was preferentially found in association with active Epstein-Barr virus (EBV) infection.
MATERIALS AND METHODS
Patients. Blood samples were taken on the occasion of routine controls from children born to HIV-positive mothers followed up in our clinic. Children were included in the study only if they were over 1 year of age and the status of HIV infection was documented by at least two cultures for HIV and by at least two polymerase chain reaction (PCR) assays for the detection of HIV genome. Children born to HIV-infected mothers and documented to be HIVnegative as described above served as controls. Additionally, blood was drawn from pediatric patients suffering from acute EBV infection (infectious mononucleosis) as diagnosed by the clinical symptoms and the detection of IgM specific to EBV capsid antigen.
Isolation and culture ofPBMC. PBMC were isolated from heparinized venous blood of patients and controls by Ficoll-Hypaque density gradient centrifugation. The cells were then resuspended in RPM1 1640 medium (GIBCO BRL, Basel, Switzerland) supplemented with 10% AB+ serum (ICNIFlow Laboratories, Allschwil, Switzerfand), 2 mmollL glutamine, 50 pg/mL streptomycin, and 100 U/mL penicillin (Sigma, Buchs, Switzerland) and cultured at a concentration of IO6 cells/mL for 16 hours to 24 hours at 37°C in a 5% COz atmosphere.
Flow cytornetry analysis.
Freshly isolated PBMC (0.5 X lo6 cells/mL) were stained using phycoerythrin (PE)-or fluorescein isothiocyanate (FITC) conjugated anti-CD3 (anti-Leu-4). anti-CD4 Analysis of the phenotype of apoptotic cells was performed using flow cytometry as described," taking advantage of the fact that apoptotic and nonapoptotic cells form distinct cell populations in light scattergrams, reflecting their smaller size and nuclear fragmentation. PBMC were isolated and cultured for 16 to 24 hours as described above before staining with MoAbs. Expression of cell surface markers was then analyzed by flow cytometry. Gates were set on the cell populations consisting of smaller, apoptotic cells (region I), and on larger, nonapoptotic cells (region 2). Expression of CD45 was found to be decreased in region I , confirming the presence of apoptosis in the cells gated in this region? Expression of cell surface markers was compared between the cells in region I and region 2. No distinct population of smaller cells corresponding to region 1 was found in three experiments assessing freshly isolated cells from healthy controls or HIV-positive patients, or in cultured (16 to 24 hours) PBMC from healthy controls or HIV-positive. apoptosis-negative patients.
DNA extraction and agarose gel electropltoresis. DNA extraction from PBMC was performed following the protocol I in Sambrook et al. ' In brief, 5 X IO* to 15 X 10' PBMC were resuspended in 750 pL of ice cold extraction buffer (10 added before the suspension of lysed cells was placed into a water bath for 3 hours to 12 hours at 50°C. Samples were suhsequently extracted three times with an equal volume of saturated phenol pH 7.9; 0.2 mL 10 mol/L ammonium acetate was added. and DNA was precipitated with 2 mL ethanol for 2 hours to 12 hours at -20°C. DNA was pelleted by centrifugation at maximal speed for 30 minutes in the microfuge in the cold, washed with 7 0 8 ethanol. and hriefly dried in a vacuum centrifuge. Finally, DNA pellets were dissolved in 0.2 mL TE (10 mmol/L Tris, I mmol/L EDTA) pH 8.0. The DNA content was calculated from absorbance of the DNA at 260 nm and equal amounts were loaded onto a I c/c agarose gel. After electrophoresis, DNA was visualized by staining with ethidium bromide. Appearance of the ladder pattern characteristic for apoptosis on loading 10 pg of DNA was interpreted to indicate that apoptosis had occurred in a pathologically elevated percentage of cells.
Detection o f E R V in PRMC. For semiquantitative PCR. PBMC were homogenized in NET buffer (10 mmol/L Tris-HCI. pH 8: 10 mmol/L EDTA. pH 7.4; 100 mrnol/L NaCl). and digested with proteinase K ( I O 0 pg/mL) in the presence of 0.5% SDS at 37°C. DNA was obtained after phenolkhloroform extraction and precipitated with ethanol (2.5 vol) in the presence of sodium acetate (3 mol/L, 0.1 vol). After centrifugation at 7.000,q for 30 minutes. DNA was dissolved in sterile water and stored at -20°C.
The Namalwa cell line. which contains two copies of EBV-DNA sequences per cell was used for the control range. The first range point contained 1 pg of Namalwa ( 1 pg = 150.000 cells = 300.000 copies). Serial 10-fold dilutions were performed to obtain a range of 1 pg to I pg of EBV-DNA sequence (300.OOO copies to 0. Staristical analysis. Numbers were expressed as mean 2 SE. Statistical significance was evaluated by Student's r-test for unmatched pairs. tracted from PBMCs from nine healthy controls showed no signs of apoptosis after culturing the cells for 16 to 24 hours (Fig 1 and Table l ) . However, in 12 of 16 HIV-infected children, 16 to 24 hours culture of the PBMCs in the absence of any exogenously added stimulus was ensued by the "lad- der" pattern in DNA gel electrophoresis characteristic for apoptosis. Experiments with both controls and HIV-infected children showed no signs of apoptosis in freshly isolated PBMC not subjected to prior culturing, confirming earlier reports.'""
RESULTS

Apoptosis occurs in PBMCs of vertically HN-infected children when cultured in vitro. Analysis of DNA ex-
To define the factors associated with apoptosis. we first compared the results of our investigations for apoptosis with laboratory data from our patients. Independent of their apoptosis-status, HIV-infected children had a statistically significant lower ratio of CD4'/CD8' T cells than the controls: 2.0 ? 0.3 (mean t SE) for the controls versus 0.5 ? 0.1 (0.4 -t 0.2) for the patients with (without) signs of apoptosis (P S .01 for both apoptosis-positive and apoptosisnegative children when compared with controls). The mean age of our controls (3.1 ? 0.7 years) was lower than that of apoptosis-positive (6.2 +-I . 1 years) and apoptosis-negative (5.5 +-1.3 years) HIV-infected patients. However, none of these parameters differed significantly between those HIVinfected children displaying signs of apoptosis and those who did not.
Apoptosis occurs in lymphocytes nctiwted in vivo. Apoptosis of mature lymphocytes has been observed to occur after cellular activatior~'~.'~; however, we have found apoptosis in PBMC not exposed to in vitro stimuli, eg, mitogens. This finding is suggestive for activation already within the host. To explore this possibility, we examined the patients' PBMCs ex vivo for the expression of activation-associated markers by flow cytometry. The receptor for interleukin-2 (IL-2R; CD25) is expressed on T cells after activation. 
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However, no patient or any control displayed >S% CD3'/ IL-2R' lymphocytes on examination of PBMC ex vivo (data not shown); this was not due to a defect associated with the IL-2R itself, because the T cells of both HIV-negative and HIV-positive patients could express IL-2R on stimulation with phytohemagglutin (PHA) in vitro (data not shown). By contrast, in patients with PBMCs undergoing apoptosis, an elevated percentage of T cells expressed HLA-DR. another activation-associated surface antigen: S -t I % and 8 5 4% (mean 5 SE) of the lymphocytes of HIV-negative controls and of HIV-infected children with no apparent apoptosis of PBMCs, respectively, coexpressed CD3 and HLA-DR, but 3 I % 5 4% of the lymphocytes from the patients with signs of apoptosis were CD3'MLA-DR' (P S .OOl when compared with the controls, and P .OOS when compared with the apoptosis-negative patients) ( Table 1 and Fig 2) . The activated T cells were predominantly CD8' T cells ( Table  1 and Fig 3) . We next examined which cells were undergoing apoptosis. PBMC were cultured for 16 to 24 hours and subsequently analyzed by Row cytometry. In light scattergrams apoptotic and nonapoptotic cells form distinct populations6 (Fig 4) . Expression of cell surface markers was compared between cell populations containing apoptotic and nonapoptotic cells by gating on the respective cell populations. Of all cells assessed, 1 S% and 64% fell into the apoptotic (region I ) and nonapoptotic (region 2) cell population, respectively (Fig 4) . Within the cell population containing apoptotic cells, 34% of the cells coexpressed CD3 and HLA-DR, as opposed to S% of the cells within the nonapoptotic cells. T cells within the apoptosis-positive cell population were predominantly of the CD8' phenotype (CD4/CD8 ratio O.3), whereas in the nonapoptotic cell compartment, the CD4/CD8 ratio was 0.9. We conclude that in patients with PBMCs undergoing apoptosis a marked expansion of activated T cells, mainly of the CD8' phenotype, occurs and that this cell population is at risk to undergo activation-induced cell death. These findings are in agreement with previously published data."." Preliminary longitudinal assessment of the patients with apoptosis showed persistence of increased CD8' T-cell activation (data not shown).
Occurrence of apoptosis in HIV-infected children coincides with active EBV infection. We next approached the question why the T cells had been activated in vivo. Expansion of a CD8'/IL-2R-/HLA-DR' lymphocyte population has been suggested to be indicative for a state of chronic activation caused by a chronically active viral infection.lx A well-studied and frequently encountered example of an agent leading to such a condition is EBV. Assessing the PBMC of three patients with acute EBV infection (infectious mononucleosis) by fluorescence-activated cell sorter (FACS) analysis for expression of T-cell activation markers and by agarose gel analysis for apoptosis, we found a high percentage of activated T cells, predominantly of the CD8' phenotype as measured by coexpression of CD8 and HLA-DR molecules (Table l) . Less than S% of the lymphocytes of these patients expressed IL-2R (data not shown). Apoptosis was detected after overnight culture without the addition of exogenous mitogens, but not in freshly isolated PBMC. These findings are in agreement with previous reports describing apoptosis in infectious mononu~leosis'~'" and resemble those in HIVinfected children with apoptosis presented here.
We hypothesized that reactivation of a latent chronically persisting viral infection or, especially in a pediatric patient population, primoinfection with such an agent could contribute to apoptosis in HIV-infected patients. We compared the results of apoptosis and T-cell activation on the one hand with the EBV status of our patients on the other hand (Table  2) , EBV serving as one example for such viruses, as it has been specifically reported to reactivate in HIV-infected patients with progressive immunodeficiency."" We assessed PBMC of the 16 HIV-infected patients and seven controls for the presence of EBV genome by semiquantitative PCR (Fig S) ; furthermore, tissues suspected on clinical grounds to harbor replicating EBV were assessed for EBV genome, with apoptosis had increased levels of EBV genome (>30 too (lymphomas, tonsils in one patient with recurring toncopies) in the peripheral blood indicating substantial viral sillar hyperplasia after tonsillectomy, tongue with oral hairy replication. In two of the remaining four patients with leukoplakia). As shown in Table 2 , eight of the 12 children apoptosis, EBV genome was detected in oral hairy leukopla-
Controls Probands
No of EBV copies Table 21 ,30,000 t o 300,000 copies; lanes 3, 4, and 6 (probands no. 16, 18, 23, Table 2 ). 300 t o 3,000 copies; lanes 5 and 7 (probands no. 15 and 20, Table 21 , -3 copies; lane 2 (proband no. 11, Table 2 ). <3 copies.
For personal use only. on April 5, 2017 . by guest www.bloodjournal.org From kia and hyperplastic tonsillar tissue. By contrast, in probands without apoptosis, either controls or HIV-infected children, no or only low levels of EBV genome ( 5 3 0 copies) could be detected. Five of the 10 patients with apoptosis and detectable EBV in peripheral blood and/or tissue showed markedly elevated IgG antibody titers to EBV (Table 2 ). In two of these five patients, IgM to VCA was detected. The clinical findings of the patients are listed in Table 2 .
DISCUSSION
We and others have shown that apoptosis of PBMC in HIV-infected subjects can be observed only after the cells have been ~u l t u r e d .~~~~ ' ' This finding may reflect that apoptotic cells are rapidly cleared by the reticulo-endothelial system in vivo, whereas in vitro apoptotic cells would accumulate and thus become d e t e~t a b l e .~~ The alternative hypothesis, that cells may only die on culture, seems unlikely, as lymphocytes in a preapoptotic state can be demonstrated in freshly isolated peripheral lymphocytes.' ' Apoptosis has recently been debated as potential cause of T cell depletion during HIV infection.' Reports describing apoptosis as a consequence of in vitro activation of HIVinfected PBMC have led to the hypothesis that HIV itself might predispose PBMC to die rather than to proliferate on stimulation. However, we and others2*" have shown that apoptosis occurs without stimulation in vitro. This, and the fact that neither in the present nor in previous studies, all HIV-infected patients showed apoptosis makes HIV as the sole trigger of apoptosis unlikely. Our observation that the occurrence of apoptosis was correlated to expansion of CD8+/IL-2R-/HLA-DR+ T cells (Fig 3) suggests that factors additional to HIV and able to induce such T-cell activation are involved in the process of triggering apoptosis; the lack of expression of IL-2R may contribute to apoptosis by hindering adequate T-cell activation.
Herpes viruses and, within this group of agents, especially EBV are known to be potent inducers of expansion and activation of CD8+ T cell^.'^*^^ Furthermore, HIV-negative individuals with primary EBV infection show, beside expansion of CD8+/IL-2R-/HLA-DR+ cells, also apoptosis (our results and Tomkinson et all9 and Uehara et al2O). We, therefore, wondered whether herpes viruses such as EBV, which after primary infection are not cleared from the body and, due to defective regulation, may reactivate in HIV-infected i n d i v i d~a l s , 2~~~~~~~ are relevant for the occurrence of apoptosis in HIV-infected individuals. We choose to assess the presence of EBV genome in PBMC and specific tissues as a parameter for active viral repli~ation.~~,~' Our observation of apoptosis occurring in all of the 10 patients in whom we detected increased levels of EBV genome in peripheral blood and/or in EBV-related lesions indicating increased viral replication, suggests that active EBV may be one potential trigger of apoptosis. Because HIV-infected individuals with EBV-related disorders also tend to have elevated antibody responses to EBV,28-31 the magnitude of the serologic response to EBV observed in six of the 10 patients with detectable EBV genome in blood and/or tissue further supports the activity of EBV infection. Our microbiologic investigations were limited to EBV. Thus, the potential role of other herpes viruses or other agents for the triggering of apoptosis remains to be evaluated.
Most adults have already contracted EBV infection when they acquire HIV. By contrast, vertical HIV infection of children occurs before primoinfection with EBV. In vertically HIV-infected children, manifestation of clinical symptoms shows a bimodal distribution. One patient population suffers from an early onset of disease, usually within the first year of life, whereas another patient population exhibits a slowly progressive disease, comparable to that in adults.'2,'3 It is tempting to speculate that the time of primary infection and/or subsequent reactivation of latent infection with EBV in the immunocompromised host may be one determinant of the clinical course in vertically HIV-infected children by triggering apoptosis.
Apoptosis of T cells was also found in macaques infected with the simian immunodeficiency virus, but not in HIVinfected chimpanzees, paralleled by the development of clinical illness in the first, but not in the latter.3 It would be interesting to investigate whether chimpanzees can be productively infected with EBV, or whether the EBV-related herpes virus pan, which has been found in chimpanzees, induces apoptosis in the T cells of these animals.
Finally, two facts may question the relevance of cell death by apoptosis for T-cell depletion and loss of immunocompetence in the acquired immune deficiency syndrome (AIDS). First, in this and previous studies,I3 activation and activationinduced cell death predominantly affected CD8+ T cells, whereas progression to AIDS is commonly associated with loss of CD4+ T cells. Second, in HIV-negative individuals, T-cell death by apoptosis as occurring in primary EBV infection does not induce long-lasting T-cell lymphopenia; additional HIV-associated factors would have to be postulated. Further studies are needed to evaluate the contribution of herpes viral-triggered apoptosis to the T-cell loss leading to AIDS.
